Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children | Zendy

Beatriz Larrú | Zendy; Salvador Resino | Zendy; José M. Bellón | Zendy; Ma Isabel de José | Zendy; Clàudia Fortuny | Zendy; María Luisa Navarro | Zendy; M.D. Gurbindo | Zendy; J. T. Ramos | Zendy; Pere SolerPalacín | Zendy; J. A. Leon | Zendy; Miguel Asensi | Zendy; María José Mellado | Zendy; María Ángeles MuñozFernández | Zendy

Open Access

Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children

Author(s) -

Beatriz Larrú,

Salvador Resino,

José M. Bellón,

Ma Isabel de José,

Clàudia Fortuny,

María Luisa Navarro,

M.D. Gurbindo,

J. T. Ramos,

Pere SolerPalacín,

J. A. Leon,

Miguel Asensi,

María José Mellado,

María Ángeles MuñozFernández

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm436

Subject(s) - lopinavir , ritonavir , lopinavir/ritonavir , medicine , viral load , logistic regression , immunology , antiretroviral therapy , human immunodeficiency virus (hiv)

Immune recovery after prolonged highly active antiretroviral therapy (HAART) with lopinavir/ritonavir has been reported in adults but not in children. Our study aimed at evaluating the long-term use of lopinavir/ritonavir among children in a clinical setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research